| Cellular immune correlates of protection against symptomatic pandemic influenza S Sridhar, S Begom, A Bermingham, K Hoschler, W Adamson, W Carman, ... Nature medicine 19 (10), 1305-1312, 2013 | 898 | 2013 |
| Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis A Roy, M Eisenhut, RJ Harris, LC Rodrigues, S Sridhar, S Habermann, ... British Medical Journal Publishing Group 349, g4643, 2014 | 686 | 2014 |
| Effect of dengue serostatus on dengue vaccine safety and efficacy S Sridhar, A Luedtke, E Langevin, M Zhu, M Bonaparte, T Machabert, ... New England Journal of Medicine 379 (4), 327-340, 2018 | 674 | 2018 |
| Influenza Vaccination Strategies: Comparing Inactivated and Live Attenuated Influenza Vaccines S Sridhar, KA Brokstad, RJ Cox Vaccines 3 (2), 373-389, 2015 | 218 | 2015 |
| Prognostic value of interferon-γ release assays and tuberculin skin test in predicting the development of active tuberculosis (UK PREDICT TB): a prospective cohort study I Abubakar, F Drobniewski, J Southern, AJ Sitch, C Jackson, M Lipman, ... The Lancet Infectious Diseases 18 (10), 1077-1087, 2018 | 189 | 2018 |
| Heterologous two-dose vaccination with simian adenovirus and poxvirus vectors elicits long-lasting cellular immunity to influenza virus A in healthy adults L Coughlan, S Sridhar, R Payne, M Edmans, A Milicic, N Venkatraman, ... EBioMedicine 29, 146-154, 2018 | 145 | 2018 |
| Heterologous two-dose vaccination with simian adenovirus and poxvirus vectors elicits long-lasting cellular immunity to influenza virus a in healthy adults L Coughlan, S Sridhar, R Payne, M Edmans, A Milicic, N Venkatraman, ... EBioMedicine 29, 146-154, 2018 | 145 | 2018 |
| Single‐dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei A Reyes‐Sandoval, S Sridhar, T Berthoud, AC Moore, JT Harty, ... European journal of immunology 38 (3), 732-741, 2008 | 135 | 2008 |
| Heterosubtypic T-cell immunity to influenza in humans: challenges for universal T-cell influenza vaccines S Sridhar Frontiers in immunology 7, 195, 2016 | 106 | 2016 |
| Enumeration of functional T-cell subsets by fluorescence-immunospot defines signatures of pathogen burden in tuberculosis R Casey, D Blumenkrantz, K Millington, D Montamat-Sicotte, OM Kon, ... PLoS One 5 (12), e15619, 2010 | 104 | 2010 |
| Clinical development of Ebola vaccines S Sridhar Therapeutic advances in vaccines 3 (5-6), 125-138, 2015 | 96 | 2015 |
| Single-dose protection against Plasmodium berghei by a simian adenovirus vector using a human cytomegalovirus promoter containing intron A S Sridhar, A Reyes-Sandoval, SJ Draper, AC Moore, SC Gilbert, GP Gao, ... Journal of virology 82 (8), 3822-3833, 2008 | 78 | 2008 |
| Harnessing local and systemic immunity for vaccines against tuberculosis PCL Beverley, S Sridhar, A Lalvani, EZ Tchilian Mucosal immunology 7 (1), 20-26, 2014 | 76 | 2014 |
| Ethnicity and mycobacterial lineage as determinants of tuberculosis disease phenotype M Pareek, J Evans, J Innes, G Smith, S Hingley-Wilson, KE Lougheed, ... Thorax 68 (3), 221-229, 2013 | 76 | 2013 |
| Prime and target immunization protects against liver-stage malaria in mice A Gola, D Silman, AA Walters, S Sridhar, S Uderhardt, AM Salman, ... Science translational medicine 10 (460), eaap9128, 2018 | 74 | 2018 |
| Safety and Immunogenicity of a Heterologous Prime-Boost Ebola Virus Vaccine Regimen in Healthy Adults in the United Kingdom and Senegal N Venkatraman, BP Ndiaye, G Bowyer, D Wade, S Sridhar, D Wright, ... The Journal of infectious diseases 219 (8), 1187-1197, 2019 | 67 | 2019 |
| A comparison between two strategies for monitoring hepatic function during antituberculous therapy A Singanayagam, S Sridhar, J Dhariwal, D Abdel-Aziz, K Munro, ... American journal of respiratory and critical care medicine 185 (6), 653-659, 2012 | 60 | 2012 |
| Safety and efficacy of novel malaria vaccine regimens of RTS, S/AS01B alone, or with concomitant ChAd63-MVA-vectored vaccines expressing ME-TRAP T Rampling, KJ Ewer, G Bowyer, NJ Edwards, D Wright, S Sridhar, ... NPJ vaccines 3 (1), 49, 2018 | 54 | 2018 |
| Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2, randomised, dose … S Sridhar, A Joaquin, MI Bonaparte, A Bueso, AL Chabanon, A Chen, ... The Lancet Infectious Diseases 22 (5), 636-648, 2022 | 53 | 2022 |
| Predominance of heterosubtypic IFN-gamma-only-secreting effector memory T cells in pandemic H1N1 naive adults S Sridhar, S Begom, A Bermingham, K Roberts, W Barclay, P Openshaw, ... IMMUNOLOGY 135, 65-65, 2011 | 53 | 2011 |
